Aldeyra Therapeutics, Inc Reports Second Quarter and Year to Date 2015 Financial Results and Provides Development Updates
August 11, 2015Aldeyra announced plans for clinical testing of systematic administration of NS2 and addition of a clinical program on allergic conjunctivitis which provides a new market opportunity. In the second quarter, Aldeyra raised $19.6 million in net proceeds.
More »
Adynxx Reports Positive Results for Phase 2b Study of AYX1
August 11, 2015AYX1, treatment under development for prevention of chronic pain following surgery, demonstrates sustained reduction of movement-evoked pain and pain at rest following knee replacement surgery with a single preoperative administration.
More »
Tandem Diabetes Care®, Inc Named Among Best Places to Work in San Diego
August 7, 2015Tandem was selected by the San Diego Business Journal based on its excellent workplace policies, practices, philosophy, systems, demographics, and employee experience. CEO, Kim Blickenstaff, recognizes the employees as “best in the business.”
More »